baber/WOPTO huggingface dataset:
Patent EP-1558443-B2 (EP)
Inventor: Müller Ulrich
IPC: G10K11/168
Filed: 2003-10-30
Granted: 2015-03-04
Abstract: A method of producing a porous, plate-shaped metallic composite, wherein metallic fibers are compressed and fused together in a single step.
Patent EP-1778406-B2 (EP)
Inventor: MILLI OTTAVIO
IPC: B05B7/16
Filed: 2005-08-08
Granted: 2015-02-11
Abstract: A spray painting device comprising a heated tube ( 15 ) for pre-heating the carrier fluid for painting.
Patent EP-1929039-B2 (EP)
Inventor: VAN EIJK MICHAEL JOSEPHUS THERESIA
IPC: G16B30/10
Filed: 2006-09-21
Granted: 2013-11-20
Abstract: Efficient methods are disclosed for the high throughput identification of mutations in genes in members of mutagenized populations. The methods comprise DNA isolation, pooling, amplification, creation of libraries, high throughput sequencing of libraries, preferably by sequencing-by-synthesis technologies, identification of mutations and identification of the member of the population carrying the mutation and identification of the mutation.
Patent EP-0365815-B2 (EP)
Inventor: MORIARTY BARBARA E
IPC: G01N33/18
Filed: 1989-09-13
Granted: 1999-08-04
Abstract: The performance of a treating agent added to a body of water employed in a cooling tower is continuously monitored by real-time analysis of a spectral or chemical characteristic of an inert tracer proportioned to the treating agent, said characteristic being indicative of tracer concentration, and converted to a voltage analog. The voltage analog is compared to a monitor value representing par performance and if performance is nonstandard (nonpar) a signal is generated which alters the output of a pump which feeds the dosage of treating agent containing proportioned tracer.
Patent EP-0597045-B2 (EP)
Inventor: CORMA CANOS AVELINO
IPC: B01J29/06
Filed: 1992-11-06
Granted: 2001-04-25
Abstract: Material used as matrix and active in catalysts for the catalytic cracking of heavy fractions of petroleum (FCC), consisting in a fibrous magnesian silicate of the sepiolite type modified by substitution of Mg2+ terminal by trivalent cations and which is active and selective for bottom conversion and for passivation of basic compounds of nitrogen present in food products.
Patent EP-0639899-B2 (EP)
Inventor: UMEDA NARUMI
IPC: H04B1/707
Filed: 1994-03-03
Granted: 2008-02-27
Abstract: Chacune des stations mobiles de 121 à 123 fixe des temps d'attente d1, d2 et d3 de manière aléatoire pour chaque message à transmettre en fonction du débit de symboles reçus en provenance de la station de base, de façon à retarder le signal de transmission. La station de base (11) diffuse le signal de réception de manière inversée afin d'extraire le débit de symboles standard pour chaque station mobile, et permet à chaque démodulateur de recevoir la sortie de diffusion inversée au débit extrait et de démoduler le signal de réception.
Patent EP-0656207-B2 (EP)
Inventor: BERRY JULIANNE
IPC: C09K3/30
Filed: 1992-06-08
Granted: 2009-07-22
Abstract: An aerosol formulation contains mometasone furoate and as propellant 1,1,1,2,3,3,3 and is suitable for treating asthma by nasal or oral administration.
Patent JP-3036786-B2 (JP)
IPC: A61K31/397
Filed: 1990-04-21
Granted: 2000-04-24
Abstract: Piperazine derivatives of formula <CHEM> and their pharmaceutically acceptable acid addition salts are disclosed. In the formula n is 1 or 2, R is hydrogen or lower alkyl, R<1> is an aryl or nitrogen containing heteroaryl radical, R<2> is hydrogen or lower alkyl, R<3> is aryl, C4-8 alkyl or aryl(lower)alkyl and X is a functionalised group of specified meaning. The compounds exhibit activity as 5-HT1A antagonists and can be used, into alia, for the treatment of CNS disorders, such as anxiety.
Patent JP-H0516980-B2 (JP)
IPC: B24B13/00
Filed: 1981-07-15
Abstract: An aspherical surface generating method and apparatus which optimizes the path of a moving cutting tool tip to fit a given aspherical surface of revolution to be cut on a rotating work piece engaged by the moving tip. The apparatus is a modified spherical generator, the modifications and control of which adapt it to continuously match the curvature of the path of the moving cutting tool tip to that of the given aspherical surface of revolution by adjusting the dynamic machine center in the direction of the evolute of the curve, i.e. along the locus of the radius of curvature of the given surface at the tool tip.
Patent JP-H0446959-B2 (JP)
IPC: A01N57/14
Filed: 1983-06-21
Abstract: Compounds of the formula   <IMAGE>   wherein R1 and R2 which may be identical to or different from each other, are each straight or branched alkyl of 1 to 3 carbon atoms; R3 is alkyl of 1 to 8 carbon atoms; X is sulfur or oxygen; Y is chlorine, bromine or fluorine; and n is 1 or 2. The compounds are useful as pesticides.
Patent JP-H0454807-B2 (JP)
IPC: F01K11/02
Filed: 1986-06-13
Abstract: A connection between a steam turbine (1) and a condenser (2), the turbine being supported by an admission end bearing (7) and by an exhaust end bearing (8), and exhausting axially into an end-located condenser via an exhaust sleeve (3) which is connected to the turbine stator at one end and which has its other end connected to the condenser via a sealed resilient connection (4), the turbine-condenser connection including the improvement whereby a tubular duct (44) passes freely through the condenser along the turbine axis, one end (45) of said duct being fixed to the fixed parts of the turbine exhaust end bearing, which parts are connected to said sleeve (3), and the other end (43) of said duct being connected to a flange (38) having the same diameter as the condenser end of the exhaust sleeve, with a sealed resilient connection (39) being provided between the periphery of said flange and the condenser.
Patent JP-S6017041-B2 (JP)
IPC: G01B11/30
Filed: 1979-11-02
Abstract: Two radiation components differing from each other with regard to their state of polarization or their wavelength are directed onto closely adjacent points of the object to be measured. The reflected components are recombined and are fed to a polarization- or wavelength-dependent phase shifter periodically shifting the phase positions of the two components by  lambda /2 against each other. A phase shift of one of the components caused by the object to be measured is fully compensated for by periodically shifting the phase position of the other component at particular points in time, which can be determined, for example, by means of a connected analyzer and a photodetector. The values of the control voltage effecting the periodical phase shift in the phase shifter are measured at those points in time at which the phase difference between the two components equals zero. These values are proportional to the difference in height between the points of incidence of the two radiation components on the object surface or the slope of the object surface.
Patent JP-S631233-B2 (JP)
IPC: G01B5/02
Filed: 1982-08-19
Abstract: PURPOSE:To compute the size of a frame which fits the user's physical constitution quickly and accurately, by providing an operation and display device for frame sizes, which computes a seat angle, SAR, and the like, based on each detected signal that is inputted from a riding attitude detecting device, and displays the result. CONSTITUTION:Position detectors detect a horizontal distance X1 from a hanger part 28 to a handle supporting part 23, a height Y1 from the hanger part 28 to the handle supporting part 23, a horizontal distance X2 from the hanger part 28 to a saddle supporting part 39, and a height Y2 from the hanger part 28 to the saddle supporting part 39. Then the detected signal from each position detector is sent to an A/D converter 43 through a main control box 42 and converted into the digital signal. The result is inputted and stored in an operation and display device 44. The operation and display device 44 performs the operation in accordance with programs. The operations are sequentially performed in accordance with the programs. At this stage, the kind of a bicycle, the diameter of a wheel, and the like, which are requested by the user are inputted. The size of the frame which fits the user's physical constitution is computed. The result is stored in the operation and display device 44. A frame drawing is outputted together with the computed result.
Patent JP-3539659-B2 (JP)
IPC: H01L23/50
Filed: 1997-06-05
Granted: 2004-07-07
Abstract: PROBLEM TO BE SOLVED: To prevent separation of a small piece of a lead frame or a resin block upon cutting and removing a dummy resin body and a lead frame part, by connecting the lead frame part to a support member in the dummy resin body via a connection piece and supporting the lead frame part by the support member. SOLUTION: A support member 24 and a lead frame part 9 to be cut and removed are connected with a fine connection piece 30 such that when the lead frame part 9 is cut at both ends and separated from a read frame 1, the cut lead frame part 9 is integrated with the dummy resin body formed in a dummy resin formation region 22. Further, a connection piece is provided such that it projects from a connection resin formation region 27 into an opening 23 of the dummy resin formation region 22. By this arrangement, the very small lead frame part 9 can be prevented from being solely removing from the read frame 1, and it can be discarded integrally with the dummy resin body to be removed.
Patent JP-S6125708-B2 (JP)
IPC: C07D211/60
Filed: 1983-08-12
Abstract: Compounds of the formula:   <IMAGE>   wherein R1, R2, R3, R4 and R5 each represent a hydrogen atom, a halogen atom, a (C1-4)alkoxy radical, a (C1-4)alkylthio radical, a halogeno(C1-4)alkyl radical, a (C1-4)alkyl radical or a cycloalkyl-alkoxy-alkoxy radical or two of the adjacent R symbols together form a methylenedioxy or ethylenedioxy radical, R6 represents a hydrogen atom, a (C1-4)alkyl radical, a (C3-6)cycloalkyl radical or a (C3-6)cycloalkyl-(C1-4)alkyl radical, and R7, R8 and R9 each represent a hydrogen atom or a methoxy radical, are new compounds possessing pharmacological properties; they are useful as calcium antagonists and as antihypertensives.
Patent JP-H0826254-B2 (JP)
IPC: C09D175/00
Filed: 1991-06-20
Abstract: A cationic resin containing blocked isocyanate groups which is suitable for use in electrodeposition is disclosed. The cationic resin is derived from an epoxy resin and contains in the resin molecule cationic salt groups, active hydrogen groups and blocked isocyanate groups. The blocked isocyanate groups are incorporated into the resin molecule by reacting the epoxy resin with a compound selected from the class consisting of mercapto compounds and acid group-containing compounds where the compounds also contain blocked isocyanate groups. The resin can be formulated into an electrocoating composition which is free of lead and yet provides outstanding corrosion resistance when electrodeposited over steel substrates. The outstanding corrosion resistance can be attained when the substrate has not been given a chrome rinse which is conventional in pretreating the steel substrate before electrodeposition.
Patent JP-H0760147-B2 (JP)
IPC: G01N33/92
Filed: 1992-06-01
Abstract: Method and electrolyte buffer useful in the analysis of samples comprising glycoproteins by capillary zone electrophoresis. The buffer comprises at least one agent capable of complexing with sugar moieties of glycoproteins. The buffer preferably further comprises at least one pH modifier. An embodiment of the buffer comprises boric acid as the complexing agent and sodium hydroxide as the pH modifier.   <IMAGE>
Patent JP-2529060-B2 (JP)
IPC: E02F3/26
Filed: 1992-06-11
Granted: 1996-08-28
Abstract: The present invention relates to drilling equipment with a tool which can be lowered into the ground. The drilling tool can be operated over a large speed range with considerable disintegration if the drive for the drilling tool is formed from at least two drives (28, 30) which are coupled via a superimposed or differential mechanism (32). <IMAGE>
Patent JP-H0773602-B2 (JP)
IPC: A61K6/898
Filed: 1988-07-23
Abstract: PCT No. PCT/JP89/00726 Sec. 371 Date Mar. 21, 1990 Sec. 102(e) Date Mar. 21, 1990 PCT Filed Jul. 20, 1989 PCT Pub. No. WO90/00892 PCT Pub. Date Feb. 8, 1990.This invention relates to a hardening material for medical and dental use which is composed of a powder of calcium phosphate and a hardening liquid. A subject of the present invention is to provide a hardening material wherein a calcified hard tissue analogous to body hard tissue capable of making chemically a sufficient bond with body hard tissue is formed in a body within relatively short time passage. To attain the above-described objective, the hardening material for medical and dental use relating to the present invention is composed of a calcium phosphate powder and a hardening liquid and also of at least either one of collagen and/or collagen derivatives in a state of powder or solution, and the calcium phosphate powder contains a powder of  alpha -tricalcium phosphate [ alpha -Ca3(PO4)2]and/or tetracalcium phosphate [Ca4(PO4)2O] as an essential component and the hardening liquid comprises at least one acid selected from inorganic acids and acetic acid.
Patent JP-2799803-B2 (JP)
IPC: C11D1/12
Filed: 1992-07-23
Granted: 1998-09-21
Abstract: A tinting shampoo with an efficient and gentle cleansing effect and improved colour absorption which contains at least one direct dyestuff in a water-based surfactant mixture comprising at least an anion-active surfactant in a proportion of about 5 to 35% by weight, especially a mixture of sulphosuccinate and a lauroyl sarcosinate, 0.5 to 10% by weight of a surface-active amine oxide, and about 2.5 to about 15% by weight of an alkyl polyglycoside, and, optionally, about 0.5 to about 10% by weight of an amphoteric surfactant and (or) about 0.5 to about 5% by weight of a further non-ionic surfactant.
Patent JP-2814957-B2 (JP)
IPC: B42F13/22
Filed: 1995-08-09
Granted: 1998-10-27
Abstract: In this ring binder, a pair of opposing swing base plates 3 are connected together at two locations near the center of their longitudinal swinging edges 3a by means of a joint mechanism 6 through operative engagement between the recessed joint section 61 having a projection 63 and the extended joint section 62 having a slot 64, so that the opposing swing base plates 3 are pivotally movable together in unison, and the swinging edges 3a are pivotally movable together toward and away from the top face 21a of the recessed section 21 in the fixed base plate 2. <IMAGE>
Patent JP-H0615521-B2 (JP)
IPC: C07C309/42
Filed: 1990-08-24
Abstract: The invention relates to a process of producing carbonate esters wherein an alkyl chloroformate is reacted with a phenolsulfonate in an alkaline medium and discloses the improvement whereby dialkylcarbonate formation is reduced by adding an acidifying agent to the reaction mixture after the reaction and before precipitation of the alkylsulfophenyl carbonate.
Patent JP-3046315-B2 (JP)
IPC: A61B18/22
Filed: 1989-09-05
Granted: 2000-05-29
Abstract: USE : For applying laser beams to tissue of human or animal to perform incision, transpiration or thermotherapy, and for use when expanding constricted part caused by cholesterol in narrow passage in organic tissue e.g. blood vessel. @(33pp Dwg.No.1,2/13)@.
Patent JP-3031760-B2 (JP)
IPC: H03D3/00
Filed: 1991-09-11
Granted: 2000-04-10
Abstract: In order to reduce the disturbances caused by the head switch in a videotape recorder, in an arrangement for demodulating an FM modulated signal, a fixed value in the hold circuit (12) which circuit is used for maintaining the fixed value for the signal during the head switch, is selected such that it is situated at a value the interpolated signal would have had during the head switch time interval (T1) at an instant situated between 0.3 T1 and 0.8 T1 in the head switch interval. This may be realized by an extension with a delay unit which realizes a delay Tv for which holds:  0.3 T1 < Tv < 0.8 T1. <IMAGE>
Patent JP-2505218-B2 (JP)
IPC: G01N33/537
Filed: 1987-09-29
Granted: 1996-06-05
Abstract: Hybridomas and their secreted paratopic molecules that immunoreact with apolipoprotein A-I are disclosed, as are assay methods for determining the presence and amount of apo A-I, and diagnostic systems useful in performing those determinations. Monoclonal paratopic molecules secreted by hybridomas having ATCC accession numbers HB 9200, HB 9201, HB 9202, HB 9203 and HB 9204 are utilized.
Patent JP-3694934-B2 (JP)
IPC: H04W88/02
Filed: 1995-09-28
Granted: 2005-09-14
Abstract: PROBLEM TO BE SOLVED: To reduce surrounding environmental noise when the telephone set is used as a portable telephone set and to attain memo recording without any modification when the telephone set is folded into two. SOLUTION: A 2nd casing 101 having an opposite face 101 is hinged with a 1st casing 100 having an opposite face 100a by a hinge 102. A 1st receiving microphone 26 receives voice from directions of an opening 104 provided to the opposite face 101a of a 2nd case 101 and a 2nd receiving microphone 28 receives voice from directions of an opening 107 provided to the face 101b opposite to the opposed face. The 1st and 2nd reception microphones 26, 28 are added differentially to reduce environment noise. When the casings 100, 101 are set close by approaching the opposed faces to cause a 2-fold state, a casing opening/closing detection means is used to activate a changeover means thereby stopping the 1st receiving microphone 26 and activating only the 2nd receiving microphone 28.
Patent JP-3095200-B2 (JP)
IPC: A61C5/06
Filed: 1994-09-26
Granted: 2000-10-03
Abstract: A syringe having a stopper configured at least partly as a membrane surface. The stopper is prestressed opposite to the direction of insertion of a rotary piston so that it assumes a stable position at rest. After displacement by the rotary piston, the membrane surface reversibly returns to this stable position after it is depressurized.
Patent JP-H0614043-B2 (JP)
IPC: G01N33/58
Filed: 1988-10-21
Abstract: Peridinin-chlorophyll-protein complexes are provided for use as fluorescent labels and are particularly useful in diagnostic assays employing as a reagent a fluorescent compound conjugated to a member of a specific binding pair, wherein the pair consists of a biochemical ligand and a receptor and the diagnostic assay comprises a step in which the conjugate binds to its complementary binding-pair member.
Patent JP-3075968-B2 (JP)
IPC: F24F11/02
Filed: 1995-11-10
Granted: 2000-08-14
Abstract: PROBLEM TO BE SOLVED: To perform resetting, when extended control means runs away, without suspending an operation. SOLUTION: Reset ports of a plurality of extended microcomputers 22a, 22b, 22c are connected in parallel to reset signal output ports of a main microcomputer 21. Respective indoor units 14a,... are connected to the extended microcomputers through signal lines. The respective indoor units 14a,... and the extended microcomputers, respectively, are connected to each other through one-to-one serial line circuits. The extended microcomputers transmit data to the main microcomputer 21 every predetermined interval. When input of data from the extended microcomputers is interrupted for a predetermined period of time, the main microcomputer 21 outputs a reset signal to reset the extended microcomputers.
Patent JP-H0480741-B2 (JP)
IPC: C07C2/76
Filed: 1986-12-09
Abstract: Superior tolerance to catalyst coking in a process for production of aromatics from C₂ to C₅ hydrocarbons is obtained with a catalytic composite comprising a gallium component and a crystalline aluminosilicate zeolite incor­porated into a phosphorus-containing alumina matrix. A five-fold reduction in the coke content of the spent catalyst of the instant invention is observed which is directly attributable to the phosphorus-containing alumina matrix. A novel method of preparing this catalyst is presented, along with a novel process for the dehydrocyclo­dimerization of C₂-C₅ aliphatic hydrocarbons using this catalyst system.
Patent JP-2572513-B2 (JP)
IPC: A61K35/00
Filed: 1992-11-04
Granted: 1997-01-16
Abstract: The invention relates to a thrombin of human or animal origin, which is free of infectious agents and can be prepared by activation of prothrombin which is subjected to a heat treatment to inactivate infectious agents.
Patent JP-3171174-B2 (JP)
IPC: G02B5/20
Filed: 1998-11-06
Granted: 2001-05-28
Abstract: PROBLEM TO BE SOLVED: To obtain an alignment division, vertical alignment (MVA) type liquid crystal display device having excellent display characteristics and a wide angle of a visual field by disposing specified spacers on a transparent electrode on black matrices formed by overlapping two or more of parts of red, green and blue colored layers. SOLUTION: Two or more of parts of red, green and blue colored layers are overlapped to form black matrices and spacers comprising part of a projecting pattern for divided alignment and/or the same material as the material of the pattern are disposed on a transparent electrode on the black matrices. Red pixels 1R, green pixels 1G and blue pixels 1B are formed and black matrices are formed by overlapping red and blue colored layers, red and green colored layers and blue and green colored layers. A black matrix is formed at the corner parts of a lattice by overlapping red, blue and green colored layers and the projecting pattern on the black matrix acts as spacers. One spacer is formed per pixel.
Patent JP-3482991-B2 (JP)
IPC: A61L31/12
Filed: 1998-10-27
Granted: 2004-01-06
Abstract: A high bending strength and high density material for osteosynthesis, which comprises a biodegradable and bioabsorbable crystalline thermoplastic polymer material, and a high strength implant material, comprising a composite material in which a bioceramics powder of from 0.2 to 50  mu m in particle size is dispersed in the polymer material, wherein crystals of the polymer material are pressure-oriented not in a uni-axial direction but basically in parallel with a plurality of reference axes; and a production method by pressure orientation, which comprises preparing in advance a biodegradable and bioabsorbable crystalline thermoplastic polymer material or a dispersed mixture of the polymer material and a bioceramics powder and melt-molding it into a pre-molded material which is then press-charged at a cold temperature into a cavity of a closed type forming mold, thereby obtaining an oriented molding. Since the osteosynthesis and implant materials are dense and high strength oriented moldings having less anisotropy in which crystals are oriented in parallel with a plurality of reference axes, excellent ideal biomaterials can be provided which have appropriate hydrolysis property, can maintain sufficient strength during a period required for bone union and are degraded and absorbed at such a rate that they do not induce inflammatory reactions after healing of the fractured bones so that re-operation is not required. <IMAGE>
Patent JP-3237882-B2 (JP)
IPC: A61P3/06
Filed: 1991-12-05
Granted: 2001-12-10
Abstract: The invention relates to bile acid derivatives of the formula I G1-X-G2(I) in which G1 and G2 are bile acid radicals or modified bile acid radicals in the form of the free acids, the esters or amides, the salt forms and also the forms derivatized on the alcohol groups and X is a bridge group or a single covalent bond, it being possible for G1 and G2 to be optionally bonded via X. The compounds according to the invention have a high affinity for the specific bile acid transport system of the small intestine and inhibit bile acid absorption in a concentration-dependent and competitive manner.